The President Of Amphivena Therapeutics
JeanMarie Guenot is the president of the Francisco-based business Amphivena Therapeutics Inc ., an organization primarily based in San Francisco that produces immune system treatments for the cure of cancer. She has been a business manager for more than 20 years in public and private market sectors and is also engaged in business oriented improvement and task management for R&D. Through her organization, Guenot LLC, she provides dedicated assessment solutions like project management, licensing, mergers and acquisition, finance and alliance management services to pharmaceuticals and biotechnology companies.
JeanMarie Guenot is an accomplished business professional in the community of pharmaceutical drugs and has an unparalleled volume of expertise in constructing and restoring organizations. Her effectiveness speaks volumes about her eagerness to become the best in her field. JeanMarie Guenot has a considerable collection of achievements and this article should touch on a few of them.
Amphivena Therapeutics Inc
Founded in 2012, this San Francisco-based organization which raised around $9.7 million in 2015. Amphivena Therapeutics is designed to eliminate blood malignancies with a cutting-edge treatment that harnesses the sufferer’s very own immune system to eradicate the growth of tumor cells. The business produces revolutionary immunotherapy solutions that focus on hematologic types of cancer and is powered by its vision of getting rid of blood cancers
Accomplished Performance Records
Before acquiring the position of being president, she worked with Hoffman-LaRoche in Shanghai and Basel as a business consultant. JeanMarie has also previously worked as a vice president of Corporate and Business Development, PDL BioPharma. It is during this time that she headed the acquisitions, licensing, and alliance management and mergers. She is what a person would take into consideration if they were looking for a very powerful, well achieved and zealous career woman, particularly in a male-oriented industry. Read more about Jeanmarie Guenot’s medical mission and about her company in the article: Amphivena Therapeutics Achieves Development Milestones Under Agreement With Janssen